Investing in Entera Bio Ltd (ENTX): What You Must Know

Anna Perez

Entera Bio Ltd’s recent filing unveils that its Chief Executive Officer Toledano Miranda Jayne acquired Company’s shares for reported $19912.0 on Dec 29 ’25. In the deal valued at $1.81 per share,11,000 shares were bought. As a result of this transaction, Toledano Miranda Jayne now holds 426,575 shares worth roughly $0.67 million.

Aegis Capital initiated its Entera Bio Ltd [ENTX] rating to a Buy in a research note published on March 22, 2021; the price target was $12.

Price Performance Review of ENTX

On Tuesday, Entera Bio Ltd [NASDAQ:ENTX] saw its stock fall -11.30% to $1.57. Over the last five days, the stock has lost -12.78%. Entera Bio Ltd shares have fallen nearly -30.22% since the year began. Nevertheless, the stocks have fallen -19.07% over the past one year. While a 52-week high of $3.22 was reached on 01/02/26, a 52-week low of $1.50 was recorded on 01/06/26.

Levels Of Support And Resistance For ENTX Stock

The 24-hour chart illustrates a support level at 1.4900, which if violated will result in even more drops to 1.4100. On the upside, there is a resistance level at 1.7300. A further resistance level may holdings at 1.8900.

How much short interest is there in Entera Bio Ltd?

A steep rise in short interest was recorded in Entera Bio Ltd stocks on 2025-12-15, dropping by 59300.0 shares to a total of 0.1 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-14 was 0.16 million shares. There was a decline of -57.2%, which implies that there is a negative sentiment for the stock.

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.